Daylight Photodynamic Therapy for Actinic Keratosis and Skin Field Cancerization
NCT03013647
·
clinicaltrials.gov ↗
NA
Phase
UNKNOWN
Status
20
Enrollment
OTHER
Sponsor class
Conditions
Actinic Keratosis
Interventions
DRUG:
Methyl Aminolevulinate
Sponsor
University of Sao Paulo General Hospital